Cytopia Merger with Toronto-based YM BioSci... (f pain. AeroLEF met all endpoints in a r...)

Cytopia Merger with Toronto-based YM BioSciences Inc.

Date:10/5/2009

f pain. AeroLEF met all endpoints in a randomized Phase II trial and is currently being prepared for late-stage development internationally.

For further information please visit our website at: www.cytopia.com.au

For information on YM Biosciences, please visit their website at www.ymbiosciences.com

(i)The Implementation Agreement provides for Cytopia to use commercially reasonable endeavours to ensure that each holder of a Cytopia Option agrees to the cancellation of the Cytopia options held by that holder. Unless all holders of Cytopia Options agree to the cancellation of their options, Cytopia will be required to propound the Option Scheme.

(ii)This is based on a 20 day VWAP of Cytopia and YM on 25 September 2009 of A$0.1276 and C$1.8435 respectively using an $A/$Canadian exchange rate of 0.9469.

(iii)The Effective Date is the day upon which the Schemes become effective by lodgement of the Court order with ASIC

(iv)Cytopia is required to obtain the consent by or on behalf of the Commonwealth of Australia to its proposed change in control (as the grantee company) under two specific Grants.

SOURCE Cytopia Ltd.

SOURCE Cytopia Ltd.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7
Related biology technology :

1. YM BIOSCIENCES ANNOUNCES OFFER FOR CYTOPIA LTD., AN AUSTRALIAN CANCER-FOCUSED DEVELOPMENT COMPANY
2. Cytopia Presentation on VDA CYT997 at AACR Conference
3. Cytopia Scientific Presentation on JAK2 Inhibitor Program at American Chemical Society Conference
4. Cytopia Letter to Progen Shareholders
5. Cytopia and Other Progen Shareholders Maintain Call for Meeting
6. Presentation on Cytopias JAK2 Inhibitor Program in Myeloproliferative Disorders
7. Cytopia Strengthens Scientific Team With US-Based Drug Development Specialist
8. Cytopia Presentation on JAK2 Inhibitor at American Association for Cancer Research
9. Sorrento Therapeutics, Inc. and QuikByte Software, Inc. Complete Merger
10. Schering-Plough Shareholders Approve Merger With Merck
11. TorreyPines Cancels Special Meeting of Stockholders in Order to Pursue Merger Transaction

Post Your Comments:

(Date:11/18/2009)..., Calif., Nov. 18 Sangam...ay that data from the University of Pennsylvania i...amo,s zinc finger nuclease (ZFN) based product, SB...urely disclosed on the internet. ,, Data were p...Pennsylvania School of Medicine from a single subj...

(Date:11/18/2009)...alif., Nov. 18 Masimo ...y(TM) and Measure-Through Motion and Low-Perfusion...-based Uni.H.A., one of the largest healthcare Gro...igned a multi-year purchasing agreement for "gold ... agreement offers preferred contract pricing to Un...

(Date:11/18/2009)...YORK, Nov. 18 Reportlinker.com ann...ble in its catalogue. ,, Biotechnology Reagen...www.reportlinker.com/p0164375/Biotechnology-Reagen...rnewswire&utm_medium=pr&utm_campaign=prnew...omplex chemical compounds used in a range of biote...

(Date:11/18/2009)... Promega Corporation and SwitchGear Genomics ...tein interactions. , Madi...Corporation and SwitchGear Genomics announce a nov...ons. Results of a study using the HaloCHIP™ ...rate the ability to correlate DNA binding events t...

Breaking Biology Technology:Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS 2 Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 2 Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 3 Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 4 Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 2 Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 3 Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 4 Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 5 Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 6 Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 7 Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 8 Promega and SwitchGear Publish Findings from Combined Technologies that Correlate Binding Events and Transcriptional Activity 2

[2] Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS [0] Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products [0] Reportlinker Adds Biotechnology Reagents - A Global Market Perspective [0] Promega and SwitchGear Publish Findings from Combined Technologies that Correlate Binding Events and Transcriptional Activity

..., Mass., July 16 U.S. Genomics today announced,th...artment of Homeland,Security (DHS) Science and Tec... the Bioagent Autonomous Networked Detectors (BAND...velopment, testing and optimization of,the company...on of airborne,pathogens using single molecule DNA...

...niversity of California, San Diego School of Medic...ure of normal, human liver cells that can model in...de a realistic environment to evaluate possible tr...uly 16 issue of PLoS ONE, will allow pharmaceuti...tes or possible vaccines for the HCV infection, wh...

...UE, Wash., July 15 drugstore.com, inc.,(Nasdaq: ...y, vision, and,pharmacy products, will announce it...ring a conference call on Monday, July 28, 2008 at...he second quarter 2008 earnings will,be distribute...TM) Web site,at http://www.investor.drugstore.com...

Other Biology Technology:U.S. Genomics Awarded $9.1 Million Contract for Development of Advanced Biosensor by the U.S. Department of Homeland Security 2 Improved culture system for hepatitis C virus infection 2 drugstore.com, inc. to Announce Second Quarter 2008 Results During Conference Call on Monday, July 28, 2008 at 5:00 p.m. ET 2

U.S. Genomics Awarded $9.1 Million Contract for Development of Advanced Biosensor by the U.S. Department of Homeland Security Improved culture system for hepatitis C virus infection drugstore.com, inc. to Announce Second Quarter 2008 Results During Conference Call on Monday, July 28, 2008 at 5:00 p.m. ET

(Date:11/20/2009)...sts from the Marine Biogeochemistry and Geology an...tory (NRL) organized and led a team of university ...to initiate methane hydrate exploration in the Bea...ediment contribution to Arctic climate change. , ...s a research platform, three cross-shelf transects...

(Date:11/20/2009)...he estimated 4.6 million Americans involved in the...iratory symptoms due to poor air quality in horse ...en earlier this year by investigators at Tufts Uni..., The studywhich polled more than 80 New England...duals working in barns complained of coughing, whe...

(Date:11/20/2009)...l gene into yeast, researchers from Delft Universi... improvements in bioethanol production from agricu... and elimination of the major by-product glycerol,...ntific journal Applied and Environmental Microbio...e yeast Saccharomyces cerevisiae from sugars obtai...

[0] International expedition investigates climate change, alternative fuels in Arctic [0] Barn personnel experience higher-than-average rates of respiratory symptoms [0] Delft breakthrough in bioethanol production from agricultural waste

...ade by a cancer-causing virus that was thought to ...ically needed by the virus to initiate an infectio...n T lymphotropic virus type 1 (HTLV-1) and a prote...virus, so-called accessory proteins, proteins that...ggested that the virus could live without. , But...

...of transmitting the virus that causes most cases o...ing and informing sexual partners of infection. Th...urnal of Infectious Diseases, now available online...how that knowledge of infection would lead to decr...o others. But Anna Wald, MD, MPH, and colleagues ...

...red a new cellular secret that may explain how cer...rs that makes treatment especially difficult. If t...alled metastasis -- can be understood well enough ... developed for patients with metastatic cancers. ,... Mayo researchers focused on odd protrusions obser...

Other Biology News:Cancer virus protein needed for successful infection 2 Mayo Clinic researchers discover cancer cells may move via wave stimulation 2 Mayo Clinic researchers discover cancer cells may move via wave stimulation 3

Cancer virus protein needed for successful infection Knowledge of infection may prevent spread of herpes virus Mayo Clinic researchers discover cancer cells may move via wave stimulation

Mouse Anti-Human DCAMKL2 Monoclonal Antibody, Unconjugated, Clone 2A5 from Novus Biologicals

System Gold® Microbore HPLC with 32 Karat™ Software. from Beckman Coulter

Mimic Sf9 Insect Cells from Invitrogen

... ambient HPLC. Contains connections and on-board d... devices such as RI and/or UV detectors. Also cont...erfacing to strip chart recorders. Includes an inp...r. On-board analog-to-digital conversion with RS-2...

Biology Products:

Mouse Anti-Human DCAMKL2 Monoclonal Antibody, Unconjugated, Clone 2A5 from Novus Biologicals System Gold® Microbore HPLC with 32 Karat™ Software. from Beckman Coulter Mimic Sf9 Insect Cells from Invitrogen miniDAWN from Wyatt Technology

Cytopia Merger with Toronto-based YM BioSci...(f pain. AeroLEF met all endpoints in a r...)